Compare ENGN & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENGN | AMN |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | Canada | United States |
| Employees | 82 | N/A |
| Industry | | Assisted Living Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 647.1M | 731.0M |
| IPO Year | N/A | 2001 |
| Metric | ENGN | AMN |
|---|---|---|
| Price | $7.17 | $17.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $21.00 | ★ $22.25 |
| AVG Volume (30 Days) | 342.2K | ★ 815.3K |
| Earning Date | 03-09-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,988,454,000.00 |
| Revenue This Year | N/A | $17.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.53 |
| 52 Week Low | $2.66 | $14.97 |
| 52 Week High | $12.25 | $23.74 |
| Indicator | ENGN | AMN |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 41.58 |
| Support Level | $6.04 | $17.78 |
| Resistance Level | $7.33 | $21.35 |
| Average True Range (ATR) | 0.53 | 0.86 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 66.67 | 18.35 |
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.